Atomexetine ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 17 | 多系統萎縮症 | 1 |
17. 多系統萎縮症
臨床試験数 : 119 / 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02796209 (ClinicalTrials.gov) | May 2016 | 7/6/2016 | Norepinephrine Transporter Blockade, Autonomic Failure | Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure | Multiple System Atrophy (MSA) | Drug: Atomexetine;Drug: Placebo | NYU Langone Health | Vanderbilt University Medical Center | Completed | 40 Years | 80 Years | All | 40 | Phase 2 | United States |